'Pharma bro' Martin Shkreli's company files for bankruptcy

KaloBios Pharmaceuticals filed for Chapter 11 bankruptcy on Tuesday, only shortly after firing their notorious "pharma bro" CEO Martin Shkreli. The company listed both its assets and liabilities in the range of $1 million to $10 million, Reuters reports.

Shkreli, who was also the CEO of Turing Pharmaceuticals, was fired from KaloBios and resigned from Turing following allegations of securities fraud and conspiracy. Shkreli earned notoriety earlier this year after hiking the price of a life-saving AIDS and cancer drug from $13.50 to $750.

The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE

https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Explore More

Jeva Lange was the executive editor at TheWeek.com. She formerly served as The Week's deputy editor and culture critic. She is also a contributor to Screen Slate, and her writing has appeared in The New York Daily News, The Awl, Vice, and Gothamist, among other publications. Jeva lives in New York City. Follow her on Twitter.